$1.29
-0.03 (-2.27%)
Open$1.32
Previous Close$1.32
Day High$1.37
Day Low$1.27
52W High$2.99
52W Low$0.87
Volume—
Avg Volume2.49M
Market Cap95.68M
P/E Ratio—
EPS$-0.50
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+118.6% upside
Current
$1.29
$1.29
Target
$2.82
$2.82
$1.78
$2.82 avg
$3.37
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.42M | 19.36M | 17.02M |
| Net Income | -2,266,322 | -2,263,432 | -1,770,857 |
| Profit Margin | -11.7% | -11.7% | -10.4% |
| EBITDA | -3,805,934 | -3,485,255 | -2,994,447 |
| Free Cash Flow | -1,809,844 | -1,626,073 | -1,604,802 |
| Rev Growth | +9.6% | -8.7% | +9.0% |
| Debt/Equity | 1.27 | 1.74 | 1.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.35 | -1.10% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $419.87 | +0.42% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $150.65 | -1.02% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $525.69 | -0.38% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | +0.00% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $252.46 | -1.14% | 41.4 | 33.44B |